Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001731122-25-000607
Filing Date
2025-04-25
Accepted
2025-04-25 16:31:01
Documents
7
Period of Report
2025-04-25

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A e6511_def14a.htm DEF 14A 403248
2 GRAPHIC image_001.gif GRAPHIC 7571
3 GRAPHIC image_002.gif GRAPHIC 6119
4 GRAPHIC image_003.gif GRAPHIC 306
5 GRAPHIC image_004.gif GRAPHIC 6141
6 GRAPHIC p_001.jpg GRAPHIC 1709075
7 GRAPHIC p_002.jpg GRAPHIC 1318180
  Complete submission text file 0001731122-25-000607.txt   4589949
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-37606 | Film No.: 25874610
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)